Serge Messerlian, Teon Therapeutics CEO
March 8, 2022 02:12 PM ESTUpdated 03:18 PM
People

From J&J on­col­o­gy chief to tiny biotech start­up CEO? Serge Messer­lian talks about his big ca­reer change­up

Paul Schloesser

Associate Editor

San Fran­cis­co-based Teon Ther­a­peu­tics got it­self a new CEO — in a tran­si­tion from Big Phar­ma in­to the world of biotech.

But what sparked that tran­si­tion …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Pfiz­er look­ing to sell hos­pi­tal drugs unit — re­ports

'Ex­per­tise is a re­al thing': FDA com­mis­sion­er warns of po­lit­i­cal risk to agency

As­traZeneca CEO reaf­firms com­mit­ment to Chi­na fol­low­ing ex­ec­u­tive's de­ten­tion

Mer­ck, As­traZeneca tout Phase 3 win for can­cer-turned-rare dis­ease drug

Sanofi, Ope­nAI, For­ma­tion Bio de­but pa­tient re­cruit­ing tool, will use in Phase 3 mul­ti­ple scle­ro­sis stud­ies

sponsored

What Will It Take to Re­verse Fi­bro­sis in Pa­tients with Ad­vanced MASH?

A service from the Financial Times